gefitinib has been researched along with licochalcone a in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (licochalcone a) | Trials (licochalcone a) | Recent Studies (post-2010) (licochalcone a) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 244 | 10 | 182 |
| Protein | Taxonomy | gefitinib (IC50) | licochalcone a (IC50) |
|---|---|---|---|
| Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens (human) | 5.176 | |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | 0.97 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.6543 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gan, Y; Han, S; Li, W; Li, X | 1 |
1 other study(ies) available for gefitinib and licochalcone a
| Article | Year |
|---|---|
Licochalcone A Promotes the Ubiquitination of c-Met to Abrogate Gefitinib Resistance.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Chalcones; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Ubiquitination | 2022 |